Before revision: Pipeline In efforts to expand therapeutic offerings into other indications, PNC acquired Agilis Biotherapeutics in July 2018, a biotech company using DNA therapeutics to treat genetic disorders related to the central nervous system.
After revision: Pipeline In efforts to expand therapeutic offerings into other indications, PTC acquired Agilis Biotherapeutics in July 2018, a biotech company using DNA therapeutics to treat genetic disorders related to the central nervous system.